article
<bold>Introduction:</bold> Tunisia has made substantial and steady progress in the field of health, enabling considerable improvements in the population-health in general and child health in particular. <bold>Aim:</bold> This study examines the percentage of infants<5years with acute respiratory illness (ARI) symptoms in the last two weeks and focuses on the use antibiotics. <bold>Methods:</bold> Our work was based on the Tunisian Multiple Indicator Cluster Surveys (MICS) conducted in 2006(June-August)and 2018(march-May). To collect information about infants<5years, mothers/caretakers were interviewed. A child was considered to have an ARI if he had, during the specified period a coughing and difficult breathing which symptoms were perceived to be due to a chest problem, or both a chest problem and a blocked nose. <bold>Results:</bold> The number of households surveyed were respectively 8681 and 11225 in 2006 and 2018. The response rate increased from 95.4% to 97.8. The number of infants included went from 3053 in 2006 to 3420 in 2018. The percentage of infants with ARI symptoms in the last two weeks decreased from 6.1% to 6%. The percentage was higher in urban areas in 2006 (6.3vs5.6) and in the rural areas in 2018(7.7% vs. 5%). The age group most affected was 6 to 11 months along the years, with a percentage of 9.8% in 2006 and 8.4% in 2018. In 20018, the percentage of children with ARI symptoms in the last two weeks who had received antibiotics was 65.4%, with a sex ratio (m/f) of 1.08. Infants in urban areas were most affected : 71.4%. <bold>Conclusion:</bold> Our study showed the high percent of ARI in Tunisian infants and highlights the excessive use of antibiotics.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1183/13993003.congress-2024.pa4949
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.